World Fair for Organic Wines: the Trade Fair Will Be Back Again in Force In 2022!
14.12.2021 17:07:00 EET | Business Wire | Press release
Millésime Bio has become, over the years, the number one marketplace for professionals in the organic wine, cider, beer and spirits industries. With its digital session on 17 and 18 January 2022 and its physical fair on 24, 25 and 26 January 2022 at Montpellier Exhibition Centre, the World Fair for Organic Wines will be the first major international wine fair since the COVID crisis, a symbol that the recovery is underway.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211214005696/en/
(Photo: Gilles Lefrancq/Millésime Bio)
MILLESIME BIO 2022: A DOUBLE EVENT
Millésime Bio, traditionally the first wine, cider, beer and spirits trade fair of the year, will take place in two stages for this 2022 edition. A double event that will guarantee all professionals their participation while taking into account the sanitary constraints imposed in France and abroad.
The World fair for organic wines will start on 17 January for two days. Based on the model of the 2021 100% digital edition, more than 450 exhibitors and several thousand visitors will be able to exchange information and make initial contacts prior to the physical fair. On this occasion, visitors will discover in preview the medal-winners list of the Challenge Millésime Bio 2022 contest. From Monday 24 January to Wednesday 26 January, the physical fair will be an opportunity to get back to live tastings and meetings.
12/01/2022 - CHALLENGE MILLESIME BIO 2022
Every year, SudVinBio organises the largest international organic wine contest before the fair: the Challenge Millésime Bio contest. This year, the 15th edition of the contest will take place on Wednesday 12 January 2022.
NEW: Challenge Millésime Bio is opening up to international organic beers. The contest team will be accompanied by the SNBI (French National Union for Independent Breweries) to set up this tasting.
The medal-winning wines and beers will be available for tasting during the 3 days of the fair, in an area dedicated to the Challenge Millésime Bio.
More than 1,400 exhibitors from 20 countries will be there, in the heart of the number one organic vineyard in France, and will present about 40% of the French organic wine offer and a wide range of the international offer. This renewed enthusiasm consolidates Millésime Bio's position as the key marketplace that will set the trend for future trade fairs in a post health crisis context.
In parallel with the meetings with exhibitors, visitors will be able to attend a 2-day programme of conferences and Master Classes led by experts. The programme will include the results of a European IPSOS/Millésime Bio study on organic wine consumption habits.
"The Millésime Bio trade fair will welcome you from 17 January, to start with in its digital format. Following the success of last year's launch, we have perfected our online platform this year, in order to programme it a few days before our traditional physical event, which is back at last!
More than ever, we are listening to visitors and exhibitors to optimise the efficiency of this key event for buyers in the organic wine and spirits sector. Thus, a special place is reserved this year for the brewery and cider industries.”
Jeanne Fabre, President of the Millésime Bio Commission
ABOUT
MILLÉSIME BIO IS ORGANISED BY SUDVINBIO, OCCITANIA TRADE ASSOCIATION OF ORGANIC VINTNERS
SudVinBio is a non-profit association created in 1991. It is an interprofessional organisation representing producers (independent wineries and cooperatives) and merchants of organic wines in the Occitania region, France’s number one organic wine region. SudVinBio represents around 70% of the regional production of certified organic wines at the end of 2020 (around 700 000 hl). It orchestrates promotional and communication activities, protects the interests of its members, provides support for research and development as well as advisory services to its members.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211214005696/en/
Contact information
PRESS CONTACT
Anaïs Marchand & Fanny Courtial
+33 (0)4 72 07 42 41
fanny.courtial@clairdelune.fr – www.clairdelune.fr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 23:04:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases, today announced that the companies have entered into a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in cash, for a total equity value of approximately $10.0 billion, or approximately $8.8 billion net of estimated cash acquired. The transaction was unanimously approved by both the Vertex and Crinetics Boards of Directors and is anticipated to close in the third quarter of 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706876183/en/ Crinetics’ marketed medicine, PALSONIFY® (paltusotine), received approval from the U.S. Food and Drug Administration (FDA) in September 2025. PALSONIFY was recently approved by the European Medicines Agency (EMA) a
Ciauru Wins the Second Edition of the Reply AI Music Contest, the International Competition Dedicated to Experimentation Across AI, Music and Live Performance6.7.2026 21:30:00 EEST | Press release
The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706007611/en/ The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival First place went to Ciauru, the stage name of Simone Privitera, an Italian multi-platinum DJ and producer who integrates artificial intelligence tools into a musical practice rooted in the contemporary electronic scene. With a career that has seen him collaborate wit
Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 20266.7.2026 16:00:00 EEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on July 30, 2026. The company will host a conference call and webcast on that date to discuss the second quarter 2026 results and the second half 2026 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706560476/en/ Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 2026 A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini Street, Inc. (Nasda
Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe6.7.2026 16:00:00 EEST | Press release
Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world’s most widely used cancer immunotherapies to widen patient access across Europe. Nivolumab helped usher in the era of immuno-oncology, transforming the outlook for patients with cancers such as melanoma and lung cancer. As the originator approaches loss of exclusivity in Europe, this partnership aims to put a high-quality, EU-GMP-manufactured nivolumab biosimilar within reach of more patients, reducing healthcare burden. In 2025, Nivolumab recorded sales of approximately USD4.1 billion (Source: IQVIA/IMS) Europe — underscoring the scale of the opportunity. Under the agreement, Orion will hold the exclusive rights to register, market, distribute and sell the nivolumab biosimilar across Europe. Shilpa Biologicals will lead product developm
No-Loss Trading Platform UpsideOnly Surpasses 100,000 Users Within Weeks of Launch6.7.2026 15:48:00 EEST | Press release
Perpetuals.com Ltd (Nasdaq: PDC), today announced that UpsideOnly, its risk-free trading and market prediction platform, has seen a surge in new user sign-ups, surpassing the important milestone of 100,000 traders within weeks of its launch on May 19. UpsideOnly lets users make predictions about where global equity, commodity, forex, and crypto markets are heading without ever placing a real trade themselves. Perpetuals uses its own capital to trade on the strongest signals identified by its proprietary AI. If those trades win, Perpetuals shares the profits with the users who helped generate the signal. If the trade doesn’t make money, users lose nothing. Reaching 100,000 users so quickly after launching is a reflection of the enormous demand for a platform that flips the traditional retail trading model on its head, with early platform data showing strong engagement across asset classes, geographies and user activity: Users from more than 180 different countries $38.4 billion in cumul
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom